These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33122447)

  • 1. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait.
    David B; Bafadhel M; Koenderman L; De Soyza A
    Thorax; 2021 Feb; 76(2):188-195. PubMed ID: 33122447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
    Siddiqui SH; Pavord ID; Barnes NC; Guasconi A; Lettis S; Pascoe S; Petruzzelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3669-3676. PubMed ID: 30464449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.
    Oshagbemi OA; Odiba JO; Daniel A; Yunusa I
    Curr Drug Targets; 2019; 20(16):1670-1679. PubMed ID: 31393244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood eosinophils in COPD: friend or foe?
    Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
    Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
    Cheng SL
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
    Singh D; Wedzicha JA; Siddiqui S; de la Hoz A; Xue W; Magnussen H; Miravitlles M; Chalmers JD; Calverley PMA
    Respir Res; 2020 Sep; 21(1):240. PubMed ID: 32943047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
    Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P
    Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overuse of long-acting β
    Brunton SA; Hogarth DK
    Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise management of COPD: What is next after bronchodilation?
    Miravitlles M; Matsunaga K; Dreher M
    Ther Adv Respir Dis; 2023; 17():17534666231208630. PubMed ID: 37936381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S; Dell'Aniello S; Ernst P
    Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
    Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL; Wang HH; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2231-2238. PubMed ID: 28814851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil-to-lymphocyte ratio, and mortality outcomes in US adults.
    Hu HS; Wang Z; Jian LY; Zhao LM; Liu XD
    Front Immunol; 2023; 14():1230766. PubMed ID: 38035096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts.
    Saito Z; Yoshida M; Kojima A; Tamura K; Hasegawa T; Kuwano K
    Lung; 2020 Dec; 198(6):925-931. PubMed ID: 33068153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
    Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
    Respir Res; 2021 Feb; 22(1):54. PubMed ID: 33579297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.